Search Results - "Urano, Yasuharu"
-
1
Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice
Published in Molecular pharmacology (01-11-2010)“…Excessive hepatic glucose production through the gluconeogenesis pathway is partially responsible for the elevated glucose levels observed in patients with…”
Get more information
Journal Article -
2
FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase III. Structure determination
Published in Journal of antibiotics (01-02-2003)Get more information
Journal Article -
3
Effects of the novel Foxo1 inhibitor AS1708727 on plasma glucose and triglyceride levels in diabetic db/db mice
Published in European journal of pharmacology (25-10-2010)“…Recent evidence suggests that the forkhead transcription factor Foxo1 plays an important role in the regulation of glucose and triglyceride metabolism at the…”
Get full text
Journal Article -
4
High diastereofacial selectivity in nucleophilic additions to chiral acylsilanes
Published in Journal of the American Chemical Society (01-07-1988)Get full text
Journal Article -
5
Prevention of renal interstitial fibrosis via histone deacetylase inhibition in rats with unilateral ureteral obstruction
Published in Transplant immunology (01-05-2010)“…Abstract Acute rejection following renal transplantation has become manageable with the introduction of calcineurin inhibitors, FK506 and cyclosporine A…”
Get full text
Journal Article -
6
FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC). I. Taxonomy, fermentation, isolation and biological activities
Published in Journal of antibiotics (01-02-2003)“…A cyclic tetrapeptide FR235222, a novel immunosuppressant, has been isolated from the fermentation broth of a fungus, Acremonium sp. No. 27082. FR235222 showed…”
Get more information
Journal Article -
7
FR226807: a potent and selective phosphodiesterase type 5 inhibitor
Published in European journal of pharmacology (05-10-2001)“…We describe the pharmacological characteristics of a novel phosphodiesterase type 5 inhibitor FR226807, N-(3,4-dimethoxybenzyl)-2-{[(1…”
Get full text
Journal Article